HIP Fracture REhabilitation Programme for Elderly With Hip Fractures
Launched by HERLEV AND GENTOFTE HOSPITAL · Jan 31, 2019
Trial Information
Current as of July 21, 2025
Completed
Keywords
ClinConnect Summary
Little is known about the feasibility and effect of an intersectoral rehabilitation intervention aiming at reducing the decrease in Activities of Daily Living (ADL) ability for elderly with hip fractures. Despite positive surgical outcomes, one-quarter dies within a year after surgery, around eight percent are readmitted to hospital, and just one-third regain their pre-fracture level of physical functioning and ADL ability. After hip fracture, the loss of independence, and further decrease in ADL ability often persists beyond three months after surgery. This increases the risk of social iso...
Gender
ALL
Eligibility criteria
- Inclusion Criteria:
- • Aged 65 years or older
- • Recent proximal hip fracture (S 72.0 Medial femur fracture, S 72.1, Pertrochanteric femur fracture, S 72.2 Subtrochanteric femur fracture)
- • Living at home prior to hip fracture in Herlev, Gentofte or Lyngby-Taarbæk municipalities
- • Ability to give informed consent
- • Discharged from hospital and receiving or having received rehabilitation in one municipalities within the last 3 months from onset
- Exclusion Criteria:
- • Not expected to be discharged to home or rehabilitation centers in the municipality
- • Not able to speak and/or understand Danish
- • Have prior severe physical and /or mental disabilities
About Herlev And Gentofte Hospital
Herlev and Gentofte Hospital, a leading healthcare institution in Denmark, is dedicated to advancing medical research and patient care through innovative clinical trials. As a prominent sponsor, the hospital focuses on a wide range of therapeutic areas, leveraging its multidisciplinary expertise and state-of-the-art facilities to facilitate rigorous scientific investigation. Committed to enhancing treatment outcomes and improving patient quality of life, Herlev and Gentofte Hospital collaborates with academic institutions and industry partners to foster groundbreaking discoveries and translate research findings into clinical practice.
Contacts
Jennifer Cobb
Immunology at National Institute of Allergy and Infectious Diseases (NIAID)
Locations
Copenhagen, Herlev, Denmark
Patients applied
Timeline
First submit
Trial launched
Trial updated
Estimated completion
Not reported
Similar Trials